Published in Emerg Infect Dis on February 01, 2002
A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med (2004) 4.81
Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One (2009) 3.03
Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence (2013) 2.98
Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis. J Bacteriol (2009) 2.64
Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg Infect Dis (2007) 2.49
Clinical characteristics and prognostic factors of splenic abscess: a review of 67 cases in a single medical center of Taiwan. World J Gastroenterol (2006) 2.41
NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J Immunol (2009) 2.39
Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother (2011) 2.04
Liver abscess caused by magA+ Klebsiella pneumoniae in North America. J Clin Microbiol (2005) 1.73
Isolation of a chromosomal region of Klebsiella pneumoniae associated with allantoin metabolism and liver infection. Infect Immun (2004) 1.66
Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun (2011) 1.66
Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France. J Clin Microbiol (2011) 1.52
Molecular serotyping of Klebsiella species isolates by restriction of the amplified capsular antigen gene cluster. J Clin Microbiol (2004) 1.47
Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant. Eur J Clin Microbiol Infect Dis (2011) 1.47
Klebsiella pneumoniae in gastrointestinal tract and pyogenic liver abscess. Emerg Infect Dis (2012) 1.44
National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase. PLoS One (2013) 1.43
Characterization of integrative and conjugative element ICEKp1-associated genomic heterogeneity in a Klebsiella pneumoniae strain isolated from a primary liver abscess. J Bacteriol (2007) 1.41
Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype. J Clin Microbiol (2008) 1.34
Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008. BMC Infect Dis (2010) 1.32
Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci (2006) 1.31
Klebsiella variicola is a frequent cause of bloodstream infection in the stockholm area, and associated with higher mortality compared to K. pneumoniae. PLoS One (2014) 1.30
Fecal carriage of serotype K1 Klebsiella pneumoniae ST23 strains closely related to liver abscess isolates in Koreans living in Korea. Eur J Clin Microbiol Infect Dis (2011) 1.28
Clinical and microbiological characteristics of community-acquired thoracic empyema or complicated parapneumonic effusion caused by Klebsiella pneumoniae in Taiwan. Eur J Clin Microbiol Infect Dis (2010) 1.28
Mapping the Evolution of Hypervirulent Klebsiella pneumoniae. MBio (2015) 1.27
Risk factor analysis of invasive liver abscess caused by the K1 serotype Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis (2008) 1.23
Comparative genomics of Klebsiella pneumoniae strains with different antibiotic resistance profiles. Antimicrob Agents Chemother (2011) 1.20
Characterization of Klebsiella pneumoniae type 1 fimbriae by detection of phase variation during colonization and infection and impact on virulence. Infect Immun (2008) 1.20
Seroepidemiology of Klebsiella pneumoniae colonizing the intestinal tract of healthy Chinese and overseas Chinese adults in Asian countries. BMC Microbiol (2012) 1.19
Genetic requirements for Klebsiella pneumoniae-induced liver abscess in an oral infection model. Infect Immun (2009) 1.12
Isolation of genes involved in biofilm formation of a Klebsiella pneumoniae strain causing pyogenic liver abscess. PLoS One (2011) 1.11
Hypermucoviscosity as a virulence factor in experimental Klebsiella pneumoniae endophthalmitis. Invest Ophthalmol Vis Sci (2008) 1.10
Evidence for clonal dissemination of the serotype K1 Klebsiella pneumoniae strain causing invasive liver abscesses in Korea. J Clin Microbiol (2008) 1.10
Phosphoproteomics of Klebsiella pneumoniae NTUH-K2044 reveals a tight link between tyrosine phosphorylation and virulence. Mol Cell Proteomics (2009) 1.10
Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumoniae. Pathogens (2014) 1.10
Correlation between Klebsiella pneumoniae carrying pLVPK-derived loci and abscess formation. Eur J Clin Microbiol Infect Dis (2010) 1.07
Capsular types of Klebsiella pneumoniae revisited by wzc sequencing. PLoS One (2013) 1.07
Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than "classical" K. pneumoniae thereby enhancing its virulence. PLoS One (2011) 1.04
Small molecule suppression of carbapenem resistance in NDM-1 producing Klebsiella pneumoniae. ACS Med Chem Lett (2012) 1.04
Rapid real-time PCR assays for detection of Klebsiella pneumoniae with the rmpA or magA genes associated with the hypermucoviscosity phenotype: screening of nonhuman primates. J Mol Diagn (2009) 1.04
Dissemination of multiple drug resistance genes by class 1 integrons in Klebsiella pneumoniae isolates from four countries: a comparative study. Antimicrob Agents Chemother (2011) 1.03
Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrob Agents Chemother (2014) 1.02
Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Infect Immun (2014) 1.01
Humoral immunity against capsule polysaccharide protects the host from magA+ Klebsiella pneumoniae-induced lethal disease by evading Toll-like receptor 4 signaling. Infect Immun (2008) 1.00
Appearance of Klebsiella pneumoniae liver abscess syndrome in Argentina: case report and review of molecular mechanisms of pathogenesis. Open Microbiol J (2011) 1.00
Extended-spectrum-beta-lactamases, AmpC beta-lactamases and plasmid mediated quinolone resistance in klebsiella spp. from companion animals in Italy. PLoS One (2014) 0.99
Klebsiella pneumoniae: Going on the Offense with a Strong Defense. Microbiol Mol Biol Rev (2016) 0.98
Identification of a conserved chromosomal region encoding Klebsiella pneumoniae type 1 and type 3 fimbriae and assessment of the role of fimbriae in pathogenicity. Infect Immun (2009) 0.97
Klebsiella pneumoniae oropharyngeal carriage in rural and urban Vietnam and the effect of alcohol consumption. PLoS One (2014) 0.97
Isolation of a bacteriophage specific for a new capsular type of Klebsiella pneumoniae and characterization of its polysaccharide depolymerase. PLoS One (2013) 0.96
Use of a Dictyostelium model for isolation of genetic loci associated with phagocytosis and virulence in Klebsiella pneumoniae. Infect Immun (2010) 0.95
Long-term mortality of patients with septic ocular or central nervous system complications from pyogenic liver abscess: a population-based study. PLoS One (2012) 0.92
Sialic acid involved in hypermucoviscosity phenotype of Klebsiella pneumoniae and associated with resistance to neutrophil phagocytosis. Virulence (2014) 0.92
Molecular epidemiological characteristics of Klebsiella pneumoniae associated with bacteremia among patients with pneumonia. J Clin Microbiol (2015) 0.92
Iron trafficking as an antimicrobial target. Biometals (2009) 0.91
Biofilm formed by a hypervirulent (hypermucoviscous) variant of Klebsiella pneumoniae does not enhance serum resistance or survival in an in vivo abscess model. Virulence (2012) 0.91
The diabetic ocular environment facilitates the development of endogenous bacterial endophthalmitis. Invest Ophthalmol Vis Sci (2012) 0.88
Amino acid substitutions of MagA in Klebsiella pneumoniae affect the biosynthesis of the capsular polysaccharide. PLoS One (2012) 0.88
Structure and immunological characterization of the capsular polysaccharide of a pyrogenic liver abscess caused by Klebsiella pneumoniae: activation of macrophages through Toll-like receptor 4. J Biol Chem (2011) 0.88
Characterization of Klebsiella sp. strain 10982, a colonizer of humans that contains novel antibiotic resistance alleles and exhibits genetic similarities to plant and clinical Klebsiella isolates. Antimicrob Agents Chemother (2014) 0.88
Whole-Genome Draft Sequences of Three Multidrug-Resistant Klebsiella pneumoniae Strains Available from the American Type Culture Collection. Genome Announc (2013) 0.87
Short chain N-acylhomoserine lactone production by clinical multidrug resistant Klebsiella pneumoniae strain CSG20. Sensors (Basel) (2013) 0.87
Klebsiella pneumoniae and the pyogenic liver abscess: implications and association of the presence of rpmA genes and expression of hypermucoviscosity. Virulence (2015) 0.87
Klebsiella pneumoniae translocates across the intestinal epithelium via Rho GTPase- and phosphatidylinositol 3-kinase/Akt-dependent cell invasion. Infect Immun (2014) 0.86
Bacteremia caused by Brevundimonas species at a tertiary care hospital in Taiwan, 2000-2010. Eur J Clin Microbiol Infect Dis (2011) 0.86
Phagocytosis and Killing of Carbapenem-Resistant ST258 Klebsiella pneumoniae by Human Neutrophils. J Infect Dis (2016) 0.86
Cellobiose-specific phosphotransferase system of Klebsiella pneumoniae and its importance in biofilm formation and virulence. Infect Immun (2012) 0.86
Structural and population characterization of MrkD, the adhesive subunit of type 3 fimbriae. J Bacteriol (2013) 0.85
Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo. Infect Immun (2015) 0.84
Functions of some capsular polysaccharide biosynthetic genes in Klebsiella pneumoniae NTUH K-2044. PLoS One (2011) 0.84
Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice. Antimicrob Agents Chemother (2011) 0.84
Klebsiella pneumoniae related community-acquired acute lower respiratory infections in Cambodia: clinical characteristics and treatment. BMC Infect Dis (2012) 0.83
Genome sequence of Klebsiella oxytoca 11492-1, a nosocomial isolate possessing a FOX-5 AmpC β-lactamase. J Bacteriol (2012) 0.83
D-galactan II is an immunodominant antigen in O1 lipopolysaccharide and affects virulence in Klebsiella pneumoniae: implication in vaccine design. Front Microbiol (2014) 0.82
Association of targeted multiplex PCR with resequencing microarray for the detection of multiple respiratory pathogens. Front Microbiol (2015) 0.81
Hypermucoviscous Klebsiella syndrome without liver abscess in a patient with immunoglobulin g2 immune deficiency. Open Forum Infect Dis (2014) 0.81
First Case of Liver Abscess in Scandinavia Due to the International Hypervirulent Klebsiella Pneumoniae Clone ST23. Open Microbiol J (2014) 0.81
Epidemiology of invasive Klebsiella pneumoniae with hypermucoviscosity phenotype in a research colony of nonhuman primates. Comp Med (2009) 0.81
Optimization of pulse-field gel electrophoresis for subtyping of Klebsiella pneumoniae. Int J Environ Res Public Health (2013) 0.80
Concanavalin A protects mice from a lethal inoculation of intragastric Klebsiella pneumoniae and reduces the induced liver damage. Antimicrob Agents Chemother (2007) 0.80
Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates. Braz J Microbiol (2015) 0.79
The Klebsiella pneumoniae YfgL (BamB) lipoprotein contributes to outer membrane protein biogenesis, type-1 fimbriae expression, anti-phagocytosis, and in vivo virulence. Virulence (2016) 0.79
Klebsiella pneumoniae yggG gene product: a zinc-dependent metalloprotease. Int J Mol Sci (2011) 0.79
Structural and mechanistic studies of HpxO, a novel flavin adenine dinucleotide-dependent urate oxidase from Klebsiella pneumoniae. Biochemistry (2013) 0.79
Capsular Polysaccharide Is Involved in NLRP3 Inflammasome Activation by Klebsiella pneumoniae Serotype K1. Infect Immun (2015) 0.79
Why hypothetical protein KPN00728 of Klebsiella pneumoniae should be classified as chain C of succinate dehydrogenase? Protein J (2009) 0.79
Community-acquired Klebsiella pneumoniae meningitis in an alcoholic patient with an infected pancreatic pseudocyst; a case report and review of literature. J Med Case Rep (2007) 0.78
First report of two rapid-onset fatal infections caused by a newly emerging hypervirulent K. Pneumonia ST86 strain of serotype K2 in China. Front Microbiol (2015) 0.78
Impact of glycemic control on capsular polysaccharide biosynthesis and opsonophagocytosis of Klebsiella pneumoniae: Implications for invasive syndrome in patients with diabetes mellitus. Virulence (2016) 0.78
Changing etiology of community-acquired bacterial meningitis in adults: a nationwide multicenter study in Korea. Eur J Clin Microbiol Infect Dis (2010) 0.77
Emergence of plasmid-mediated quinolone-resistant determinants in Klebsiella pneumoniae isolates from Tehran and Qazvin provinces, Iran. J Prev Med Hyg (2015) 0.77
Prevalence of Plasmid-Mediated Quinolone Resistance Determinants and OqxAB Efflux Pumps among Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Isolated from Patients with Nosocomial Urinary Tract Infection in Tehran, Iran. Scientifica (Cairo) (2015) 0.77
Identification of a capsular variant and characterization of capsular acetylation in Klebsiella pneumoniae PLA-associated type K57. Sci Rep (2016) 0.76
Klebsiella pneumoniae Asparagine tDNAs Are Integration Hotspots for Different Genomic Islands Encoding Microcin E492 Production Determinants and Other Putative Virulence Factors Present in Hypervirulent Strains. Front Microbiol (2016) 0.76
Aspirin enhances opsonophagocytosis and is associated to a lower risk for Klebsiella pneumoniae invasive syndrome. BMC Infect Dis (2014) 0.76
Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned. Infect Dis Clin North Am (2016) 0.76
Klebsiella sweet deadly kiss. Virulence (2016) 0.76
Klebsiella pneumoniae bacteremia and capsular serotypes, Taiwan. Emerg Infect Dis (2011) 0.76
Protection against Klebsiella pneumoniae using lithium chloride in an intragastric infection model. Antimicrob Agents Chemother (2014) 0.76
Fulminant klebssiella pneumoniae pneumonia in immunocompetent non alcoholic patient. Clin Med Case Rep (2008) 0.75
CDC definitions for nosocomial infections, 1988. Am J Infect Control (1988) 27.03
Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis (1998) 7.51
Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med (1993) 6.88
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis (1989) 3.92
Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med (1991) 3.21
Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents (1999) 2.64
Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis (1991) 2.46
Necrotizing fasciitis with Klebsiella liver abscess. Clin Infect Dis (1998) 2.36
Klebsiella pulmonary infections: occurrence at one medical center and review. Rev Infect Dis (1990) 1.88
Etiology and diagnosis of pneumonia requiring ICU admission. Chest (1992) 1.86
Pyogenic liver abscess in Taiwan: emphasis on gas-forming liver abscess in diabetics. Am J Gastroenterol (1993) 1.84
Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. Clin Infect Dis (1996) 1.64
Seasonal variation in community-acquired pneumonia. Eur Respir J (1996) 1.54
Single and multiple pyogenic liver abscesses: clinical course, etiology, and results of treatment. World J Surg (1997) 1.52
False positive mononucleosis screening test results associated with Klebsiella hepatic abscess. Am J Clin Pathol (1990) 1.51
Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis (1990) 1.42
Comparison of pyogenic liver abscesses caused by Klebsiella pneumoniae and non-K. pneumoniae pathogens. J Formos Med Assoc (1995) 1.38
Pyogenic liver abscesses in patients with malignant disease: a report of 52 cases treated at a single institution. Arch Surg (1998) 1.36
Microbiology of liver and spleen abscesses. J Med Microbiol (1998) 1.33
Klebsiella bacteraemia: a report of 101 cases from National University Hospital, Singapore. J Hosp Infect (1994) 1.30
Endogenous endophthalmitis associated with pyogenic hepatic abscess. J Am Coll Surg (1996) 1.26
Tropical liver abscess. Postgrad Med J (1997) 1.24
The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. The British Thoracic Society Research Committee and The Public Health Laboratory Service. Respir Med (1992) 1.19
Cholangiocarcinoma presenting as pyogenic liver abscess: is its outcome influenced by concomitant hepatolithiasis? Am J Gastroenterol (1998) 1.17
Endogenous Klebsiella pneumoniae endophthalmitis in diabetic patients. Can J Ophthalmol (1992) 1.16
Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest (1995) 1.14
Pyogenic liver abscess: clinical manifestations and value of percutaneous catheter drainage treatment. J Formos Med Assoc (1990) 1.14
Diabetes mellitus and Klebsiella pneumoniae liver abscess in adults. Trop Geogr Med (1992) 1.09
Klebsiella meningitis in Taiwan: an overview. Epidemiol Infect (1997) 1.09
Vitrectomy for endogenous Klebsiella pneumoniae endophthalmitis with massive subretinal abscess. Ophthalmic Surg Lasers (1997) 1.08
Endogenous Klebsiella endophthalmitis. Report of two cases and review of the literature. Ophthalmology (1994) 1.08
Causal bacteria of pyogenic liver abscess. Taiwan Yi Xue Hui Za Zhi (1989) 1.07
Adult bacteremic pneumonia: bacteriology and prognostic factors. J Formos Med Assoc (1992) 1.05
The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir Med (1995) 1.03
Klebsiella pneumonia in the modern era: clinicoradiographic correlations. South Med J (1991) 1.02
Pyogenic hepatic abscess: a case for open drainage. Am Surg (1993) 1.02
Severe community-acquired pneumonia in Singapore. Singapore Med J (1996) 1.01
A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest (1993) 1.00
Diagnostic and therapeutic strategies of pyogenic liver abscess. Int Surg (1993) 1.00
Metastatic septic endophthalmitis complicating pyogenic liver abscess caused by Klebsiella pneumoniae. Aust N Z J Med (1997) 1.00
The comparison of clinical course and results of treatment between gas-forming and non-gas-forming pyogenic liver abscess. Arch Surg (1995) 0.99
Multiple scleral abscesses with recurrent bacterial endophthalmitis eight months following cataract surgery. Acta Ophthalmol (Copenh) (1990) 0.98
Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med (2000) 0.96
Klebsiella pneumoniae urinary tract infection complicated by endophthalmitis, perinephric abscess, and ecthyma gangrenosum. South Med J (1991) 0.94
The outcome of community acquired pneumonia treated on the intensive care unit. Respir Med (1990) 0.93
Klebsiella pneumoniae liver abscess with septic endophthalmitis. The role of computed tomography. J Belge Radiol (1991) 0.93
Endogenous Klebsiella endophthalmitis--a case series. Ann Acad Med Singapore (1995) 0.93
Septic metastatic endophthalmitis from Klebsiella pneumoniae liver abscess: CT and MR imaging characteristics--report of three cases. Radiology (1998) 0.91
Klebsiella pneumoniae meningitis: analysis on clinical features of thirty-two adult patients. Zhonghua Yi Xue Za Zhi (Taipei) (1997) 0.89
Klebsiella pneumoniae bacteremia: analysis of 100 episodes. J Formos Med Assoc (1990) 0.89
[Multiple hepatic and pulmonary abscesses caused by Klebsiella pneumoniae]. Enferm Infecc Microbiol Clin (1994) 0.88
Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae. Respiration (1996) 0.88
Klebsiella metastatic endophthalmitis--a complication of shock wave lithotripsy. Ophthalmic Surg (1990) 0.87
Gram-negative bacillary meningitis in adults: a recent six-year experience. J Formos Med Assoc (1993) 0.86
Rupture of pyogenic liver abscess. Am J Gastroenterol (1995) 0.86
Pyogenic liver abscess in children. J Formos Med Assoc (1994) 0.86
[A case of gas-containing liver abscess with multiple metastatic lesions]. Kansenshogaku Zasshi (1995) 0.85
Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICU. Scand J Infect Dis (1995) 0.83
Community acquired pneumonia in north eastern Australia--a hospital based study of aboriginal and non-aboriginal patients. Aust N Z J Med (1997) 0.82
Klebsiella pneumoniae panophthalmitis: a possible complication of endoscopic variceal injection sclerotherapy. Am J Gastroenterol (1998) 0.81
[Bacterial endophthalmitis caused by Klebsiella pneumoniae associated with urinary sepsis]. Enferm Infecc Microbiol Clin (1994) 0.80
Pyogenic liver abscess in beta-thalassemia major--report of two cases. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi (1994) 0.80
A case of Klebsiella pneumoniae endophthalmitis metastasized from prostatitis. Hinyokika Kiyo (1994) 0.80
[Pyogenic liver abscess]. Ryoikibetsu Shokogun Shirizu (1995) 0.80
Septic endophthalmitis associated with bacteremia and liver abscess caused by Klebsiella pneumoniae. Bol Asoc Med P R (1991) 0.80
Bilateral endogenous endophthalmitis in a patient with diabetes and renal papillary necrosis. Am J Ophthalmol (1991) 0.80
[Endogenous bacterial endophthalmitis. Report of 3 cases]. J Fr Ophtalmol (1990) 0.80
[A case of liver abscess associated with endophthalmitis caused by Klebsiella pneumoniae]. Kansenshogaku Zasshi (1993) 0.79
Ultrasound-guided percutaneous drainage of liver abscess in children. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi (1996) 0.79
Liver abscess in polycystic liver disease. J Med Assoc Thai (1995) 0.78
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis (2010) 35.92
Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev (2008) 17.77
Antibiotic resistance-the need for global solutions. Lancet Infect Dis (2013) 15.01
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis (2006) 14.63
Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med (2009) 10.60
Rapid pneumococcal evolution in response to clinical interventions. Science (2011) 9.09
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis (2006) 7.36
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis (2013) 6.60
Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis (2005) 5.58
Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int (2005) 5.49
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet (2011) 5.43
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother (2010) 5.35
A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol (2005) 5.26
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology (2012) 4.83
Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother (2006) 4.80
International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med (2004) 4.75
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis (2012) 4.62
European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl (2012) 3.98
An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis (2003) 3.93
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother (2009) 3.82
Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother (2012) 3.80
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis (2004) 3.75
Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis (2005) 3.72
Influenza vaccination of pregnant women and protection of their infants. N Engl J Med (2014) 3.68
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) (2003) 3.66
Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J Infect Dis (2002) 3.65
Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis (2010) 3.65
Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med (2004) 3.49
A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med (2004) 3.49
A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis (2007) 3.39
Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev (2007) 3.18
Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill (2015) 3.13
Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase. Clin Infect Dis (2011) 3.06
A new marker of sepsis post burn injury?*. Crit Care Med (2014) 3.05
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action. Antimicrob Resist Infect Control (2012) 3.02
Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis (2007) 2.90
Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis (2012) 2.88
Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother (2008) 2.88
Aspergillus infections in transplant recipients. Clin Microbiol Rev (2005) 2.82
The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis (2005) 2.81
Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient. Clin Infect Dis (2009) 2.75
Antimicrobial drug use and resistance in Europe. Emerg Infect Dis (2008) 2.68
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother (2011) 2.58
Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis (2012) 2.58
A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) (2003) 2.51
Society's failure to protect a precious resource: antibiotics. Lancet (2011) 2.51
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50
Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg Infect Dis (2007) 2.49
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut (2012) 2.49
Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio (2011) 2.48
Density interactions among Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in the nasopharynx of young Peruvian children. Pediatr Infect Dis J (2013) 2.47
Pneumococcal vaccination in developing countries. Lancet (2006) 2.45
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother (2006) 2.32
Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis (2007) 2.31
A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis (2003) 2.29
Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil. Antimicrob Agents Chemother (2006) 2.23
Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A (2014) 2.20
Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev (2012) 2.18
Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity (2011) 2.15
Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus. Antimicrob Agents Chemother (2005) 2.14
Gram-negative resistance: can we combat the coming of a new "Red Plague"? Med J Aust (2013) 2.12
Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis (2008) 2.11
Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol (2004) 2.10
Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. Clin Infect Dis (2012) 2.08
Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia. Clin Infect Dis (2002) 2.07
Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine (2007) 2.07
Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J (2007) 2.06
Revisiting the hand wipe versus gel rub debate: is a higher-ethanol content hand wipe more effective than an ethanol gel rub? Am J Infect Control (2010) 2.06
Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis (2005) 2.05
Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study. Lancet Infect Dis (2013) 2.04
Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures. J Antimicrob Chemother (2013) 2.04
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother (2008) 2.03
Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin Infect Dis (2005) 2.03
Infection due to Legionella species other than L. pneumophila. Clin Infect Dis (2002) 2.00
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother (2006) 1.99
Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (2006) 1.98
Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia. Antimicrob Agents Chemother (2005) 1.97